ByHeart’s nationwide recall of baby formula sparks concerns about product safety amidst a growing infant botulism outbreak.
Story Highlights
- ByHeart recalls all products due to an infant botulism outbreak.
- 15 babies in 12 states have been hospitalized.
- No unopened ByHeart products have tested positive for contamination.
- FDA and health officials are investigating the cause of the outbreak.
ByHeart’s Nationwide Recall Amid Botulism Concerns
ByHeart, a manufacturer of organic baby formula, has initiated a nationwide recall of all its products as of November 11, 2025. This decision follows a series of infant botulism cases linked to the formula, affecting at least 15 babies across 12 states since August 2025.
Although these infants were hospitalized, thankfully, no fatalities have been reported. The recall extends to all ByHeart Whole Nutrition Infant Formula and Anywhere Pack pouches, marking a significant escalation from the initial recall of two specific lots.
The company took this step after being informed by the FDA of two additional cases of infant botulism associated with their products.
ByHeart’s cofounders, Mia Funt and Ron Belldegrun, expressed their commitment to consumer safety, emphasizing in an open letter that the recall was made in close collaboration with the FDA, despite no unopened product testing positive for contamination.
Organic Baby Formula Producer ByHeart Recalls All Products In U.S. As Infant Botulism Outbreak Spreadshttps://t.co/FqywsusxrL pic.twitter.com/AH32Hb99Oo
— Forbes (@Forbes) November 11, 2025
The Investigation into Contamination
The FDA is currently investigating 84 cases of infant botulism reported since August, with 36 involving infant formula consumption. ByHeart’s formula accounts for more than a third of these cases, despite representing only 1% of the U.S. market for infant formula.
This disproportionate representation has raised alarms among health officials. California health authorities confirmed that bacteria linked to the outbreak were found in an open can of ByHeart formula, underscoring the need for thorough investigation and testing.
ByHeart, in response, has ramped up testing of all formula batches using independent third-party laboratories. The company has also opened its facilities for unrestricted testing by the FDA and California health officials.
This proactive measure aims to identify any potential sources of contamination and ensure no future risks to consumers.
Consumer Safety and Ongoing Efforts
Parents and caregivers are urged to immediately discontinue the use of ByHeart products and dispose of them. The company, which produces its formula powder in Iowa and cans it in Oregon, is cooperating fully with ongoing FDA inspections.
Infant botulism, while rare, poses serious health risks to babies under one year old, and timely intervention is critical. Symptoms include constipation, poor feeding, and muscle weakness, requiring immediate medical attention and treatment with BabyBIG, an IV medication derived from blood plasma.
ByHeart’s swift response and cooperation with authorities highlight the importance of consumer safety and transparency in the food industry. The case underscores the need for stringent safety standards and vigilant monitoring to prevent similar outbreaks in the future.
